| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |